Ligand Pharmaceuticals

LGND61

$102.80arrow_drop_down2.10%-$2.21

LGND61

$102.80

arrow_drop_down2.10%-$2.21

Performance History

Key Stats
Open	$104.41
Prev. Close	$105.01
EPS	2.33
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	102.80	105.23
52 Week Range	49.24	112.13

Ratios







EPS	2.33

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals Inc (LGND) is a biopharmaceutical company that specializes in developing and acquiring technologies for drug discovery and development. The company's mission is to create innovative medicines that address unmet medical needs and improve the lives of patients. With a focus on small molecule therapeutics, Ligand has built a diverse portfolio of drug candidates and partnered with leading pharmaceutical companies worldwide. LGND's stock price history shows a steady growth over the years, reflecting the market's confidence in the company's potential. As of [date], LGND's stock price was valued at [price], marking an increase in value compared to the previous year.

In the news, Ligand Pharmaceuticals Inc has recently announced [news]. This development showcases the company's commitment to advancing its pipeline and expanding its presence in the pharmaceutical industry. LGND's stock analysis suggests that it is a promising investment opportunity, with a positive outlook for future growth. The company's smart analysis indicates that it has a strong position in the market, with a competitive advantage over its industry peers.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Headquarters: San Diego
Employees: 76
Exchange: NASDAQ

Keep an eye on Ligand Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Ligand Pharmaceuticals 's (LGND) price per share?

The current price per share for Ligand Pharmaceuticals (LGND) is $102.8. The stock has seen a price change of -$2.21 recently, indicating a -2.1% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Ligand Pharmaceuticals (LGND)?

For Ligand Pharmaceuticals (LGND), the 52-week high is $112.13, which is 9.08% from the current price. The 52-week low is $49.24, the current price is 108.77% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Ligand Pharmaceuticals (LGND) a growth stock?

Ligand Pharmaceuticals (LGND) has shown an average price growth of 0.41% over the past three years. It has received a score of 25 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ligand Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Ligand Pharmaceuticals (LGND) stock price performance year to date (YTD)?

As of the latest data, Ligand Pharmaceuticals (LGND) has a year-to-date price change of 42.17%. Over the past month, the stock has experienced a price change of -1.48%. Over the last three months, the change has been 28.81%. Over the past six months, the figure is 40.61%. Looking at a longer horizon, the five-year price change stands at -1.15%.

help

Is Ligand Pharmaceuticals (LGND) a profitable company?

Ligand Pharmaceuticals (LGND) has a net income of $52.15M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 91.2% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 17.8% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $131.31M, although specific revenue growth data is currently not available. The gross profit is $119.75M. Operating income is noted at $9.82M. Furthermore, the EBITDA is $51.22M.

help

What is the market capitalization of Ligand Pharmaceuticals (LGND)?

Ligand Pharmaceuticals (LGND) has a market capitalization of $1.89B. The average daily trading volume is 104.72K, indicating the stock's liquidity and investor engagement.